Skip to content
lifestyle.capitolhilltimes.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Apotex Inc.
Apotex expands U.S. hospital portfolio with launch of generic Infuvite® Adult and Pediatric Injection
July 8, 2026
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals
July 1, 2026
Apotex first to receive Health Canada approval for SEVMIA™, a generic semaglutide for chronic weight management
June 30, 2026
Apotex expands ophthalmic portfolio with Health Canada approval of IHEEZO™
May 26, 2026
Apotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada
May 14, 2026
Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalent of Ozempic®
May 1, 2026
Apotex licenses exclusive Canadian rights to testosterone replacement therapy Nebido® from Grünenthal
February 11, 2026